The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Molecular mechanism of action of metformin: old or new insights?
Open accessAbstract
Metformin is the first-line drug treatment for type 2 diabetes. Globally, over 100 million patients are prescribed this drug annually. Metformin was discovered before the era of target-based drug discovery and its molecular mechanism of action remains an area of vigorous diabetes research. An improvement in our understanding of metformin's molecular targets is likely to enable target-based identification of second-generation drugs with similar properties, a development that has been impossible up to now. The notion that 5' AMP-activated protein kinase (AMPK) mediates the anti-hyperglycaemic action of metformin has recently been challenged by genetic loss-of-function studies, thrusting the AMPK-independent effects of the drug into the spotlight for the first time in more than a decade. Key AMPK-independent effects of the drug include the mitochondrial actions that have been known for many years and which are still thought to be the primary site of action of metformin. Coupled with recent evidence of AMPK-independent effects on the counter-regulatory hormone glucagon, new paradigms of AMPK-independent drug action are beginning to take shape. In this review we summarise the recent research developments on the molecular action of metformin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Metformin is an insulin-sensitizing drug, known to inhibit gluconeogenesis and lipogenesis (7)”
From Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Watterson, K. R., Bestow, D., Gallagher, J. R., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2012) · Neurosignals · doi:10.1159/000334144 · Cited by 3,395
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I. V., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,522
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Flagged first, then by citations
Research works printed but not linked: 2
- Ray RK, Kauffman GB (1999) Metal and non-metal biguanide complexes. New Age International Publishers, New Delhi
- Kazda CM, Garhyan P, Kelly RP et al (2012) 12-week treatment with glucagon receptor antagonist LY2409021 significantly lowers HbA1c and is well tolerated in patients with type 2 diabetes mellitus. Diabetologia 55(Suppl 1):S51, Abstr. 112
Cited by
Sorted by citations
Items 201–300 of 479
Anwardeen, N. R., Naja, K., & Elrayess, M. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1506767 · Cited by 29
The copper binding properties of metformin – QCM-D, XPS and nanobead agglomeration
Quan, X., Uddin, R., Heiskanen, A. R., Parmvi, M., Nilson, K., Donolato, M., Hansen, M. F., Rena, G., & Boisen, A. (2015) · Chemical Communications · doi:10.1039/c5cc04321b · Cited by 25
Self-citationPortillo-Sánchez, P., Yavuz, S., Bril, F., & Cusi, K. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0229-3 · Cited by 25
The Bidirectional Relationship between Metabolism and Immune Responses
Raval, F. (2013) · Discoveries · doi:10.15190/d.2013.6 · Cited by 27
Higgins, L., Palee, S., Chattipakorn, S. C., & Chattipakorn, N. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172489 · Cited by 24
Metformin Therapy for the Management of Infertility in Women with Polycystic Ovary Syndrome
(2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14764 · Cited by 24
Diabetes Therapies for Dementia
Moran, C., Callisaya, M. L., Srikanth, V. K., & Arvanitakis, Z. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0973-4 · Cited by 24
Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
Tseng, Y. (2016) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2016.18505 · Cited by 25
Vaughan, E. M., Johnston, C. A., Hyman, D. J., Hernandez, D. C., Hemmige, V. S., & Foreyt, J. P. (2017) · Journal of Primary Care & Community Health · doi:10.1177/2150131917745760 · Cited by 24
Therapeutic Applications of Type 2 Diabetes Mellitus Drug Metformin in Patients with Osteoarthritis
Song, P., Hwang, J. S., Park, H. C., Kim, K. K., Son, H., Kim, Y., & Lee, K. M. (2021) · Pharmaceuticals · doi:10.3390/ph14020152 · Cited by 25
Salicylic acid: old and new implications for the treatment of type 2 diabetes?
Rena, G., & Sakamoto, K. (2014) · Diabetology International · doi:10.1007/s13340-014-0177-8 · Cited by 25
Self-citationMetformin induces the AP-1 transcription factor network in normal dermal fibroblasts
Gillespie, Z. E., Wang, C., Vadan, F., Yu, T. Y., Ausió, J., KUSALIK, A. J., & Eskiw, C. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-41839-1 · Cited by 28
Metformin prevents ischaemic ventricular fibrillation in metabolically normal pigs
Lu, L., Ye, S., Scalzo, R. L., Reusch, J. E. B., Greyson, C. R., & Schwartz, G. G. (2017) · Diabetologia · doi:10.1007/s00125-017-4287-2 · Cited by 23
Tseng, C. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819895159 · Cited by 22
Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy
Staiger, H., Schaeffeler, E., Schwab, M. G., & Häring, H. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.363 · Cited by 20
Wang, Y., Wu, Z., & Hu, L. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/2520581 · Cited by 21
Eid, S. R., Moustafa, R. S. I., Salah, M. M., Hanafy, S. K., Aly, R. H., Mostafa, W. G., & Ghanem, A. I. M. (2018) · Egyptian Pediatric Association Gazette · doi:10.1016/j.epag.2018.01.002 · Cited by 22
Liao, S., Li, D., Hui, Z., McLachlan, C. S., & Zhang, Y. (2018) · ERJ Open Research · doi:10.1183/23120541.00060-2018 · Cited by 23
Garbarino, V. R., Santos, T. A., Nelson, A. R., Zhang, W. Q., Smolik, C. M., Javors, M. A., Daws, L. C., & Gould, G. G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.013 · Cited by 21
Pharmacogenetics of Antidiabetic Drugs
Srinivasan, S., Yee, S. W., & Giacomini, K. M. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.04.005 · Cited by 23
Li, W., Jin, S., Hao, J., Shi, Y., Li, W., & Jiang, L. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0180 · Cited by 20
Amoani, B., Sakyi, S. A., Mantey, R., Laing, E. F., Ephraim, R. D., Sarfo-Kantanka, O., Koffie, S., Obese, E., & Afranie, B. O. (2021) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2020.1862861 · Cited by 20
Cherkas, A., & Holota, S. M. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.01.009 · Cited by 20
Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells
Wong, V. K. W., Dong, H., Xu, L., Bai, L., Jiang, Z., Guo, Y., Kong, A. T., Wang, R., Kam, R. K. T., Law, B. Y. K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6934 · Cited by 21
Peng, Y. H., Chang, Q., Yang, N., Gu, S., Zhou, Y., Yin, L., Aa, J., Wang, G., & Sun, J. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.02.007 · Cited by 20
Cozza, A., Chinigò, C., Filicetti, E., Greco, G. I., Lappano, R., Marinaro, C., Muglia, L., Soraci, L., Corsonello, A., Lattanzio, F., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102834 · Cited by 20
Something old, something new and something very old: drugs for treating type 2 diabetes
Kaiser, D., & Oetjen, E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12624 · Cited by 19
rs622342A>C in SLC22A1 is associated with metformin pharmacokinetics and glycemic response
Naja, K., Shamieh, S. E., & Fakhoury, R. (2019) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2019.10.007 · Cited by 19
Metformin reduces the Walker-256 tumor development in obese-MSG rats via AMPK and FOXO3a
de Queiroz, E. A. I. F., Akamine, E. H., de Carvalho, M. H. C., Sampaio, S. C., & Fortes, Z. B. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.11.028 · Cited by 19
Kopietz, F., Berggreen, C., Larsson, S., Säll, J., Ekelund, M., Sakamoto, K., Degerman, E., Holm, C., & Göransson, O. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00110.2018 · Cited by 21
Self-citationEnergy metabolism homeostasis in cardiovascular diseases.
Wang, L.-Y., & Chen, C. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.12.006 · Cited by 18
Klen, J., Goričar, K., Janež, A., & Dolžan, V. (2014) · BioMed Research International · doi:10.1155/2014/934729 · Cited by 18
Metabolic Alterations at the Crossroad of Aging and Oncogenesis
Raffaghello, L., & Longo, V. D. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.01.003 · Cited by 19
Cione, E., Plastina, P., Pingitore, A., Perri, M., Caroleo, M. C., Fazio, A., Witkamp, R. F., & Meijerink, J. (2019) · Nutrients · doi:10.3390/nu11040915 · Cited by 18
Peng, C., Jiang, N., Zhao, J.-F., Liu, K., Jiang, W., & Cao, P. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115408 · Cited by 18
Ishibashi, Y., & Hirabayashi, Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658948 · Cited by 18
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies
Trapanese, V., Dagostino, A., Natale, M. R., Giofrè, F., Vatalaro, C., Melina, M., Cosentino, F., Sergi, S., Imoletti, F., Spagnuolo, R., et al. (2025) · Life · doi:10.3390/life15060843 · Cited by 19
Yang, Z., Qiao, C., Jia, Q., Chen, Z., Wang, X., liu, X., Zhang, R., Pu, K., & Wang, Z. (2022) · Theranostics · doi:10.7150/thno.75837 · Cited by 17
Saiz‐Rodríguez, M., Ochoa, D., Zubiaur, P., Navares‐Gómez, M., Román, M. C., Camargo-Mamani, P., Bueno, S. L., Villapalos‐García, G., Alcaraz, R., Mejía-Abril, G. P., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030489 · Cited by 17
Oxamate Enhances the Anti-Inflammatory and Insulin-Sensitizing Effects of Metformin in Diabetic Mice
Wu, M., Ye, W., Zheng, Y., & Zhang, S. (2017) · Pharmacology · doi:10.1159/000478909 · Cited by 17
Pharmacogenetics of Oral Antidiabetic Therapy
Ordelheide, A., de Angelis, M. H., Häring, H., & Staiger, H. (2018) · Pharmacogenomics · doi:10.2217/pgs-2017-0195 · Cited by 17
Out, M., Becker, M. L., van Schaik, R. H., Lehert, P., Stehouwer, C. D. A., & Kooy, A. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0010 · Cited by 18
Gedawy, A., Al‐Salami, H., & Dass, C. R. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.01.017 · Cited by 17
Pozzi, M., Vantaggiato, C., Brivio, F., Orso, G., & Bassi, M. T. (2024) · Translational Psychiatry · doi:10.1038/s41398-023-02686-x · Cited by 18
Dhanapalaratnam, R., Issar, T., Wang, L. L., Tran, D., Poynten, A. M., Milner, K., Kwai, N. C. G., & Krishnan, A. V. (2024) · Diabetes · doi:10.2337/db24-0365 · Cited by 17
Cai, L. F., Hu, K., Lin, L., Ai, Q., Ge, P., Liu, Y., Dai, J., Ye, B., & Zhang, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.009 · Cited by 16
Umegaki, H. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0375-0 · Cited by 17
Xiao, Y., Xu, M., Alimujiang, M., Bao, Y., Wei, L., & Yin, J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27312 · Cited by 18
Zhang, J., Li, Y. Q., Wang, Y. S., Chen, L., & Wang, X. (2021) · Theriogenology · doi:10.1016/j.theriogenology.2021.08.030 · Cited by 16
Stavri, S., Trusca, V. G., Simionescu, M., & Gafencu, A. V. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.057 · Cited by 18
Hodeib, M., Ogrodzinski, M. P., Vergnes, L., Reue, K., Karlan, B. Y., Lunt, S. Y., & Aspuria, P.-J. P. (2017) · Oncotarget · doi:10.18632/oncotarget.23661 · Cited by 15
Diabetes mellitus: The pathophysiology as a canvas for management elucidation and strategies
Iheagwam, F. N., & Iheagwam, O. T. (2025) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2025.100351 · Cited by 24
Cardiac aging: Molecular mechanisms and therapeutic interventions
Li, X., Pang, X., Sun, H., Zhang, B., Wang, H., Wu, N., & Yang, L. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107954 · Cited by 16
Therapeutic Challenges in Diabetes Prevention: We Have Not Found the “Exercise Pill”
Srinivasan, S., & Florez, J. C. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.146 · Cited by 15
Yang, Y., Zhang, X., Zhang, Y., Zhao, J., Jia, J., Liu, H., & Song, S. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.071 · Cited by 15
Miceli, D. D., Vidal, P. N., Blatter, M. F. C., Pignataro, O. P., & Castillo, V. A. (2018) · Open Veterinary Journal · doi:10.4314/ovj.v8i2.13 · Cited by 15
Singh, S. S., Naber, A., Dotz, V., Schoep, E., Memarian, E., Slieker, R. C., Elders, P. J. M., Vreeker, G. C. M., Nicolardi, S., Wuhrer, M., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001230 · Cited by 15
Abualsuod, A. M., Rutland, J. J., Watts, T. E., Pandat, S. S., Delongchamp, R. R., & Mehta, J. L. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6601-x · Cited by 15
Bandô, Y., & Geisler, J. G. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104561 · Cited by 14
Zhang, X., Zhuang, Y., Qin, T., Chang, M., Ji, X., Wang, N., Zhang, Z., Zhou, H., Wang, Q., & Li, J. Z. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154823 · Cited by 14
Anderson, A. J., Andrew, R., Homer, N. Z. M., Jones, G. C., Smith, K., Livingstone, D. E. W., Walker, B. R., & Stimson, R. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2069 · Cited by 14
García‐Briones, G. S., Ocampo‐Pérez, R., Gómez‐Durán, C. F. A., Neri-Gómez, T., & Palestino, G. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.02.022 · Cited by 14
Choumessi, A. T., Johanns, M., Beaufay, C., Hérent, M., Stroobant, V., Vertommen, D., Corbet, C., Jacobs, R., Herinckx, G., Steinberg, G. R., et al. (2019) · Biochemical Journal · doi:10.1042/bcj20190326 · Cited by 15
Metformin ameliorates bile duct ligation-induced acute hepatic injury via regulation of ER stress
Lee, C., Han, J.-H., Kim, S., Lee, H.-J., Kim, S., Nam, D.-H., Cho, D., & Woo, C.-H. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.6.169 · Cited by 14
Sangi, S., Bawadekji, A., & Ali, M. A. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_108_18 · Cited by 14
Vohra, M., Sharma, A., Mallya, S. D., Prabhu, N. B., Jayaram, P., Nagri, S. K., Umakanth, S., & Rai, P. S. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01989-y · Cited by 15
Should metformin be included in fertility treatment of PCOS patients?
Haas, J., & Bentov, Y. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.01.012 · Cited by 13
Logie, L., Lees, Z. J., Allwood, J. W., McDougall, G. J., Beall, C., & Rena, G. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13455 · Cited by 13
Self-citationAMPK activators for the prevention and treatment of neurodegenerative diseases
Neumann, N. R., Thompson, D. C., & Vasiliou, V. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1991308 · Cited by 13
Harnessing Structural Data of Insulin and Insulin Receptor for Therapeutic Designs
Lukman, S., Safar, H. A., Lee, S., & Sim, K. (2015) · Journal of Endocrinology and Metabolism · doi:10.14740/jem302w · Cited by 13
Hosseyni-Talei, S. R., Mahrooz, A., Hashemi‐Soteh, M. B., Ghaffari-Cherati, M., & Alizadeh, A. (2017) · PubMed Central · doi:10.22038/ijbms.2017.8351 · Cited by 13
Risk analysis of metformin use in prostate cancer: a national population-based study
Jo, J. K., Song, H. K., Heo, Y., Kim, M. J., & Kim, Y. J. (2023) · The Aging Male · doi:10.1080/13685538.2022.2156497 · Cited by 16
Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus
Tseng, C. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0133 · Cited by 12
Repurposing of Anticancer Stem Cell Drugs in Brain Tumors
Bahmad, H. F., Daher, D., Aljamal, A. A., Elajami, M. K., Oh, K. S., Moreno, J. C. A., Delgado, R. G., Suarez, R., Zaldivar, A., Azimi, R., et al. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554211025482 · Cited by 12
DMT efficiently inhibits hepatic gluconeogenesis by regulating the Gαq signaling pathway
Zhou, T., Ma, F., Shi, X., Xu, X., Du, T., Guo, X., Wang, G., Yu, L., Rukachaisirikul, V., Hu, L., et al. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0121 · Cited by 12
Uddin, R., Nur-E-Habiba, Rena, G., Hwu, E., & Boisen, A. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00384 · Cited by 13
Self-citationOstrovskaya, R. U., Иванов, С. В., Гудашева, Т. А., & Середенин, С. Б. (2019) · Acta Naturae · doi:10.32607/20758251-2019-11-1-48-57 · Cited by 13
Mooranian, A., Carey, L., Ionescu, C. M., Walker, D., Jones, M., Wagle, S. R., Kovačević, B., Foster, T., Chester, J., Johnston, E., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101667 · Cited by 12
Jones, M., Ionescu, C. M., Walker, D., Wagle, S. R., Kovačević, B., Chester, J., Foster, T., Johnston, E., Kuthubutheen, J., Brown, D. J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020836 · Cited by 13
Ahmed, A. R., Korany, M. A., Galal, S. M., & Ragab, M. A. A. (2023) · BMC Chemistry · doi:10.1186/s13065-023-00997-0 · Cited by 11
Floyd, J. S., Wiggins, K. L., Christiansen, M. W., Dublin, S., Longstreth, W. T., Jr., Smith, N. L., McKnight, B., Heckbert, S. R., Weiss, N. S., & Psaty, B. M. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3914 · Cited by 11
Investigation of salicylate hepatic responses in comparison with chemical analogues of the drug
Cameron, A., Logie, L., Patel, K., Bacon, S., Forteath, C., Harthill, J. E., Roberts, A. J., Sutherland, C. D., Stewart, D., Viollet, B., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.015 · Cited by 11
Self-citationEl‐Sisi, A. E., Sokar, S., El‐Sayad, M. E., Moussa, E. A., & Salim, E. I. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119839192 · Cited by 11
Formononetin suppresses hyperglycaemia through activation of GLUT4-AMPK pathway
Qnais, E. Y., Alqudah, A. M., Wedyan, M. A., Gammoh, O., Alkhateeb, H. H., & Al-Noaimi, M. Z. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e104160 · Cited by 10
Low-dose metformin requires brain Rap1 for its antidiabetic action
Lin, H., Lu, W., He, Y., Fu, Y., Kaneko, K., Huang, P., la Puente-Gomez, A. B. D., Wang, C., Yang, Y., Li, F., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu3700 · Cited by 13
The Basic Science of Metabolism in Pulmonary Arterial Hypertension
Frump, A. L., & Lahm, T. (2018) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-17.3.95 · Cited by 9
Amino acid homeostasis is a target of metformin therapy
Forteath, C., Mordi, I. R., Nisr, R. B., Gutierrez-Lara, E. J., Alqurashi, N., Phair, I. R., Cameron, A., Beall, C., Bahr, I., Mohan, M., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101750 · Cited by 11
Self-citationNaem, A. A. A.-H., Al‐Terehi, M. N., Ghafil, F. A., Ataya, F. S., Batiha, G. E., Alexiou, A. T., Papadakis, M., Welson, N. N., & Hadi, N. R. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.486 · Cited by 10
Baptista, L. C. P., Machado‐Rodrigues, A. M., & Martins, R. A. (2018) · Biology of Sport · doi:10.5114/biolsport.2018.78057 · Cited by 11
Obesity: Molecular Mechanisms, Epidemiology, Complications and Pharmacotherapy
Jaberi, S. A., Cohen, A., Saeed, Z., Ojha, S. K., Singh, J., & Adeghate, E. A. (2021) · Advances in biochemistry in health and disease · doi:10.1007/978-3-030-84763-0_13 · Cited by 10
González-Heredia, T., Hernández-Corona, D. M., González-Ortı́z, M., & Martínez‐Abundis, E. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0020 · Cited by 10
Puscheck, E. E., Bolnick, A. D., Awonuga, A. O., Yang, Y., Abdulhasan, M. A., Li, Q., Secor, E. R., Louden, E. D., Hüttemann, M., & Rappolee, D. A. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1213-6 · Cited by 10
Head and neck cancers, the neglected malignancies: present and future treatment strategies
Kulkarni, P., & Saxena, U. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.888059 · Cited by 10
Covington, B. A., & Chen, W. (2024) · Biomedicines · doi:10.3390/biomedicines12030473 · Cited by 11
NLRP3 inflammasomes pathway: a key target for Metformin
Hosseini, Y., Niknejad, A., Kashani, A. S., Gholami, M., Roustaei, M., Mohammadi, M. K., Momtaz, S., Atkin, S. L., Jamialahmadi, T., Abdolghaffari, A. H., et al. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01702-4 · Cited by 12
Metformin Attenuates Myocardium Dicarbonyl Stress Induced by Chronic Hypertriglyceridemia
Malínská, H., Škop, V., Trnovská, J., Marková, I., Svoboda, P., Kazdová, L., & Haluzı́k, M. (2018) · Physiological Research · doi:10.33549/physiolres.933606 · Cited by 10
Multidimensional mechanisms of metformin in cancer treatment
Makkar, S. S., Pandav, K. B., Hathaway, D., Paul, T., & Youssef, P. (2021) · Tumori Journal · doi:10.1177/03008916211023548 · Cited by 9
Walz, L., Jönsson, A. K., Ahlner, J., Östgren, C. J., & Druid, H. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.109935 · Cited by 9
Elksnis, A., Schiffer, T. A., Palm, F., Wang, Y., Cen, J., Turpaev, K. T., Ngamjariyawat, A., Younis, S., Huang, S., Shen, Y., et al. (2021) · Clinical Science · doi:10.1042/cs20210604 · Cited by 9
Clinical Relevance of Target Identity and Biology: Implications for Drug Discovery and Development
Patel, A. C. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113505906 · Cited by 9
Metadata
- Authors
- Rena, G., Pearson, E. R., & Sakamoto, K.
- Affiliations
- University of Dundee (GB)
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Rena, Graham
- Sakamoto, Kei
- Venue
- Diabetologia
- Published
- 2013-07-09
- Volume
- 56
- Issue
- 9
- Pages
- 1898-1906
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC3737434
- OpenAlex
- W2025130292
- Cited by
- 479
- References
- 98
- Citations by year
- 2026: 9 · 2025: 22 · 2024: 20 · 2023: 33 · 2022: 22 · 2021: 52 · 2020: 33 · 2019: 38 · 2018: 58 · 2017: 51 · 2016: 37 · 2015: 52 · 2014: 43 · 2013: 8
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetologia (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Medical Research Council (MR/K012924/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, molecular mechanisms of action, type 2 diabetes, AMPK, glucagon, therapeutic target
- MeSH terms
- Diabetes Mellitus, Type 2, Energy Metabolism, Gluconeogenesis, Humans, Metformin, Models, Biological, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review